Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
The Committee's decision to recommend the addition of vets to the list is seen as a major win for the RCVS and the BVA which together submitted evidence as part of the review, which began in autumn last year.
Professions on the list are prioritised for visas required to live and work in the UK. Employers wishing to hire professionals on the list are not required to complete the Resident Labour Market Test, meaning they don't have to advertise vacancies locally before offering the role to an employee from overseas.
The RCVS/BVA submission focused on the need for the UK immigration system to recognise that the veterinary workforce is already under capacity and that this problem is likely to be exacerbated after Brexit. This is due to the potential for increased demand for veterinary surgeons in areas such as export certification, and also the likelihood that fewer veterinary surgeons from the European Union will be joining the Register. It also reiterated the importance of veterinary surgeons in areas such as public health, food safety, disease surveillance and control, as well as education, research, clinical practice and animal welfare.
RCVS President Amanda Boag said: "We are very pleased to see that our submission, made with our colleagues at the BVA, has been welcomed by the Committee and that this recommendation will now be going to the key decision-makers at the Home Office for consideration. While we are still unaware of how the process of the UK leaving the EU will pan out, this is a very important step in ensuring the future security of the profession and mitigating against worsening workforce shortages.
"We would reiterate to the Government that the UK is currently reliant on overseas registrants to meet the demand for veterinary surgeons, with veterinary surgeons from the rest of the EU making up around 50% of new registrants each year. By adding veterinary surgeons to the Shortage Occupation List, and therefore reducing the immigration requirements needed to live and work in the UK, the Government will be helping ensure vital veterinary work continues to be done particularly in areas such as food safety and public health."
Simon Doherty, BVA President, said: "MAC’s recommendation is a huge win for animal welfare and a resounding vote of confidence in the veterinary community and the multiple benefits it realises across the UK. We are absolutely delighted that the committee has heeded our calls and recognised the need to reinstate vets on the list to keep workforce supply and resilience high in the unpredictable times ahead."
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
The RCVS Disciplinary Committee has directed that a Leeds-based veterinary surgeon, whose convictions for threatening behaviour, theft, and assault made him unfit to practise, should be removed from the Register.
At the outset of the two-day hearing, Dr Gary Samuel admitted his convictions. These related to his actions near his property in Cardiff on 10 July 2011, and were received at Cardiff Magistrates' Court on 22 November 2011. The Committee was asked to decide if these convictions made Dr Samuel unfit to practise veterinary surgery, and to decide upon any sanction.
The facts of the offences, as set out at the magistrates' court by the prosecution, were that Dr Samuel took a camera and memory card from a neighbour who was taking photographs of construction works behind his property. In doing so, he grabbed the neighbour from behind, twisting her arm, and later threatened her and her partner with a large piece of wood.
Although Dr Samuel wrote to the College saying he had pleaded guilty to the charges, he also denied some of the offences charged, suggesting that it was the neighbour who had been abusive towards him.
The Committee allowed the possibility that Dr Samuel was provoked by the taking of photographs and may have been subjected to offensive abuse by the neighbour, and considered that he acted impulsively and lost control of his actions. However, the convictions were for serious offences: the assault resulted in injury to the victim; the threatening behaviour involved a risk of injury to the victim and her partner; and, the theft involved dishonesty. Dr Samuel's conduct at the time was "reckless", and he had since displayed very limited insight into his behaviour.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The Committee considers that the offences of which the Respondent was convicted, and to which he pleaded guilty, were serious, as is reflected in the suspended sentences, community service orders, fines, restrictions and penalties imposed by the court. The Committee accepts that this is not a case in which the welfare of animals has been put at risk, but takes the view that a serious sanction is required in order to uphold the reputation of the veterinary profession, and public confidence in it, and to uphold proper standards of conduct and behaviour on the part of its members."
The Committee directed Dr Samuel's name should be removed from the Register.
5638 events were reported spontaneously, mainly by the marketing authorisation holder (61%), with the remainder largely reported by veterinary surgeons.
Of these, 5512 were reports of adverse reactions in animals: 829 concerning suspected lack of efficacy, 4638 concerning safety. The majority of reports concerned dogs (2927), cats (1426) and cattle (386).
In dogs, medicines for the control of epilepsy were most often suspected of not having performed as expected (80 reports) whilst vaccines were most commonly reported as having failed to work (71). However, the VMD points out that in many cases, vaccination failure was attributable to other causes (such as incomplete vaccination schedule).
In cats, flea spot-on products were most likely to be reported as not having worked (21). However, there are many reasons why owners may continue to see live fleas on their animal which are unrelated to product efficacy (such as reinfestation from the environment).
Notably, the majority of efficacy reports in horses (12/19) related to euthanasia products, which the report says should serve as a reminder that alternative means of euthanasia should always be available in case the chosen method does not proceed as planned.
Of the safety reports, 59.6% involved dogs, 31% cats, 4.9% horses and 3.9% rabbits. The majority concerned vaccines (1360 reports, most commonly general signs or symptoms, such as lethargy or pyrexia), parasiticides (472 reports, most commonly lethargy, emesis, inflammation/pruritus, depending on method of administration) and inflammation control (412 cases, most commonly emesis, renal insufficiency and diarrhoea, depending on the drug type).
There were 124 reports of adverse events in humans. Of those involving veterinary professionals (about a quarter):
The VMD says that reports of needle stick injuries involving vaccines with a mineral oil adjuvant are of particular concern, because they often fail to show that the injured party has received prompt and correct treatment, either because they are themselves unaware of the necessity for swift intervention, or because they do not take the product package information leaflet with them when seeking medical treatment.
Similarly, the VMD says that incidents involving injectable tilmicosin seem to be often dismissed as just a scratch, and that if you use these products, you should make sure you are fully aware of the warnings contained in the product leaflets.
To read the full report, visit: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/608968/PhV_Annual_Review_2015_v7.pdf
This, says the company, will make vaccination easier for vets and clients.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand.
Each box contains 10 individual doses which can be given to pet rabbits from 30 days of age.
The follow up service ‘can be provided personally by the veterinary surgeon or practice, or by written agreement with a veterinary services provider which is local to the client (as with the current situation for [out-of-hours] care provision)’.
The new rule comes into force on the 1st November, to allow practices to make any necessary arrangements.
The RCVS Council also decided that the temporary derogation from the usual requirement to conduct a physical examination before an animal is regarded as ‘under care’ be reviewed as a standing item at each subsequent Standards Committee meeting, until the normal guidance provisions are fully restored.
Head nurse Nicola Atkins (pictured right) said: “We are very happy and proud to have achieved our silver accreditation for cat-friendly clinic status.
“To earn this internationally-recognised award, we had to prove that we met all of the ISFM criteria, including allocating a nurse and vet at each centre who are dedicated to caring for our cats and providing ‘cat only’ waiting areas to reduce their stress.”
“We provide cats with carefully-tailored care from our stress-free waiting areas and high standards of anaesthetic protocols, which deliver an enriched stay at our hospitals.
“This also reassures owners and makes them feel more at ease about visiting our clinics with their cats.”
For more information, visit www.veterinaryvision.co.uk.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
A new injector gun for administering doramectin-based worm and scab medication to sheep has been introduced by Pfizer Animal Health. According to senior livestock vet Carolyn Hogan, the intra-muscular injection route for this medication combined with the injector’s prime-and-push design allows a single arm movement to penetrate the skin and dispense the treatment.
Davies Veterinary Specialists (DVS), the multi-specialist small animal referral centre based on the Hertfordshire/Bedfordshire border, has announced a restructuring of the ownership and management of the practice.
Following 12 years of successful operation, DVS welcomes new shareholders from the Directorial team, in order to secure the future success of the practice.
Clive Elwood succeeds Jerry Davies as Managing Director; as a consequence Clive will have a reduced clinical commitment. Richard Whitelock takes on the new role of Deputy Managing Director while remaining full time in the clinic; Mike Thomas continues as Financial Director and Jerry becomes Chairman of the Board, with some clinical and representative duties. Drs David Gould and Nat Whitley have joined Clive, Richard, Mike and Jerry as shareholders, while the Board of Directors remains unchanged.
Clive said: "This exciting development represents the next phase in the evolution of the practice and will allow a progression of management and ownership without disruption to staff or clients so that we continue to deliver leading multi-specialist care."
Jerry Davies said: "I am proud of what the practice has achieved. I am confident that the new management structure will maintain the practice ethos and bring fresh ideas that will ensure we stay at the forefront of veterinary specialist practice. As Chairman, I will continue to enjoy contributing to the growth and success of the practice that bears my name."
For further details on DVS visit the website at http://www.vetspecialists.co.uk/
Rachel Wells, an RVN and Pet Health Counsellor (PHC) from Pype Hayes Veterinary Centre in Birmingham, has won Royal Canin's annual 'Pet Health Counsellor of the Year' Awards 2013.
The ceremony, which took place earlier this month at the Forest of Arden Marriot Hotel in Birmingham, saw Rachel beat 25 other finalists to claim the Gold Award. Royal Canin presented Rachel with £1,500 worth of high-street vouchers at the annual ceremony, which celebrates veterinary professionals for promoting preventative health care and running pet health clinics in practice.
The Erdington-based PHC, was chosen by animal behaviour expert Sarah Heath for her work in weekly puppy parties, general 'nutrition mission' clinics and firework and weight clinics. She was also recognised for her one-off work in running an 'Embarrassing Pet Bodies' workshop in the summer, similar to the 'Embarrassing Bodies' Channel 4 TV documentary.
Royal Canin's Veterinary Sales and Marketing Director, Andrew Doyle, said: "It's a privilege to be able to present Rachel with the award. She has demonstrated an outstanding contribution to Pype Hayes Veterinary Centre, by running a variety of specialist sessions for owners which have proven very popular and beneficial. The Royal Canin Pet Health Counsellor scheme was set up to encourage Veterinary Nurses to advance their professional development, so it was great to see such a high level of entries this year detailing the PHCs who have set up effective clinics and services in their practice."
Rachel said: "It is an honour to receive Royal Canin's Pet Health Counsellor of the Year award. It's a fantastic opportunity and the scheme they run has given me the chance and confidence to develop specialist clinics at Pype Hayes Veterinary Centre. We have set up many sessions including weight and nutrition clinics to give our clients the specific advice and training for their pets' needs."
The module, which accounts for one hour’s CPD, is facilitated by a Boehringer Ingelheim territory manager and presented by Dr Tim Brazil BVSc, PhD, CertEM, DECEIM, MRCVS, a leading expert in equine internal medicine.
Boehringer says the presentation will help refresh veterinary professionals’ knowledge on equine lower respiratory tract disease, including Recurrent Airway Obstruction (RAO), and encourage them to feel confident and fully equipped to deal with this common respiratory scenario in practice.
During the module, attendees will be guided through two common equine respiratory cases and encouraged to discuss potential approaches to diagnosis, treatment and management in the cases he describes. The module is supported by supplementary notes which can be referred to both during and after the presentation.
Additional webinars on equine respiratory disease are also available on the Boehringer Academy website. They include: Diagnosing equine lower airway disease by Scott Pirie, Managing infectious respiratory disease by Phil Ivens, Clinical diagnostics and management of acute respiratory distress by Tim Brazil and Treatment of inflammatory airway disease by David Rendle.
To book your in-practice CPD meeting, contact your local Boehringer Ingelheim territory manager.
To view the equine respiratory disease webinars, visit www.boehringer-academy.co.uk and search for 'Inspiring CPD'.
The practice is now accepting dental referrals, including for dental, oral and maxillofacial surgery.
Hannah said: “I am proud to join the Fitzpatrick Referrals team to extend their referral offering to include this very important aspect of small animal veterinary treatment.
"Working alongside a world-class team with state-of-the-art facilities is a fantastic opportunity.”
https://www.fitzpatrickreferrals.co.uk/services/dentistry/
The BSAVA and Vets Now have signed a partnership agreement to develop a new postgraduate certificate in emergency and critical care (ECC).
The programme, which will follow the same broad structure as BSAVA's existing postgraduate certificate, will take its first group of students in May 2014.
Prof Michael Day, pictured above with Amanda Boag at BSAVA, said: "This is an exciting development to develop a qualification which will be relevant and accessible to vets in practice."
Amanda Boag added: "The combined expertise of both organisations will result in an engaging and high quality qualification in this field."
The course is led by Gary England, Professor of Comparative Veterinary Reproduction, University of Nottingham. Gary is an RCVS and European College of Animal Reproduction recognised Specialist in Veterinary Reproduction.
Improve says the course has been developed to address a growing interest among first opinion practitioners in developing their knowledge and skills in canine reproduction, so as to provide a higher level of service to their clients and to encourage responsible breeding.
The course will take place on 28 and 29 September at the Guide Dogs National Breeding Centre in Warwickshire.
David Babington MRCVS, Managing Director of Improve International, said: "It's unusual to find courses covering this topical subject which also include practical components. We have constructed the programme to ensure that it provides a balance between small group presentations and practical sessions with plenty of time for discussion and hands-on practice, enabling attendees to implement their new skills straight away."
Further details are available at: https://www.improveinternational.com/uk/course/canine-reproduction/
Photo: Ultrasound of dog with prostatic disease
Titled ‘The Five Steps of Seizure Management’, the sessions will update veterinary surgeons and nurses on:
Will Peel, Product Manager at TVM UK said: "The Lunch and Learn sessions have proved very popular with veterinary practices. Our aim is to update vets and nurses on diagnosis and management of epilepsy in general practice whilst educating them about products and services which can help them better support their patients."
TVM says it will also provided supporting literature, including guidelines and owner educational tools, designed to help veterinary staff in diagnosing and treating pets with epilepsy.
To book a Lunch and Learn, contact your local TVM UK territory manager or email help@tvm-uk.com.
'Managing Veterinary Medicines' teaches safe and responsible use of veterinary medicines and medicine regulations.
RCVS Knowledge says it will also show you how to put systems in place that will reduce errors, improve patient outcomes and improve practice systems.
It's worth six hours of CPD.
The course has been produced in collaboration between RCVS Knowledge and the Veterinary Medicines Directorate (VMD), and includes a range of webinars, podcasts and articles.
Executive Director at RCVS Knowledge, Chris Gush said: “In England alone, more than 1,700 people die yearly because of medication errors.
"While we don't know the true figures in veterinary medicine, we do know that 30% of errors reported to the VDS's VetSafe system are due to medication errors.
“That's why we think it's vital to have good robust systems in place in the practice dispensary and to use QI tools like guidelines, protocols, and checklists.
CEO of the VMD, Abi Seager said: “Managing Veterinary Medicines will help teams comply with legislation as well as keep patients, team members and clients safe when prescribing and dispensing medicine.”
The course will also prepare practices for a VMD inspection or an RCVS Practice Standards Scheme assessment.
https://learn.rcvsknowledge.org
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
The programme is the first in a new series of ‘Accelerated’ courses from the company, designed to support those starting out on their postgraduate learning journey or experienced vets who want to refresh their knowledge in a specific subject.
The Accelerated Emergency and Critical Care programme comprises 15 modules covering pathophysiology, diagnosis, management and current treatments.
The modules are delivered on a weekly basis and delegates can study at their own pace. Delegates can also access all the modules for a 12-month period so they can revisit the contents as necessary.
In addition to the modules, delegates have access to a discussion forum and four live sessions with Specialists for clinical case discussions.
At the end of the course, delegates can take a Foundation Certificate from the International School of Veterinary Postgraduate Studies (ISVPS).
The programme was developed by Specialist veterinarians, both Fellows and Members of the Australian and New Zealand College of Veterinary Scientists in Emergency and Critical Care, from Improve International’s Australian Partner, the Animal Emergency Service.
David Babington MRCVS, Business Development Director at Improve International, said: “The growing interest we are seeing from veterinarians around the world in updating their knowledge as we prepare to emerge into the post-COVID world, was the catalyst for the creation of our new Accelerated online course range.
"The Accelerated Emergency and Critical Care Programme is ideal for veterinarians at all stages of their career. It is an example of the ways we are delivering on our strategy of significantly expanding our e-learning portfolio and harnessing technologies, including video teaching and virtual/augmented reality, to offer a more engaging, affordable, accessible and rich learning experience to veterinary professionals around the world."
The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".
Novartis Animal Health has launched a 0.5L pack of the anthelmintic Zolvix to make the product more readily available for quarantine dosing, and for the smaller sheep farmer.
Novartis says that because Zolvix is a broad spectrum anthelmintic that has the ability to kill all common sheep gastro-intestinal nematodes, including those resistant to existing treatments, it has a key role to play in quarantine treatment to keep parasite infection down to a minimum.
Simon Harris, Endoparasite Brand Manager at Novartis Animal Health, said: "As the first of the new generation of the Orange or 4-AD anthelmintic group, Zolvix has demonstrated effectiveness in killing worms, even those resistant to other products.
"Sheep farmers are being encouraged to use Zolvix as a quarantine treatment that can significantly reduce worm burdens on farm. I would stress that it is essential guidelines are followed in order to preserve Zolvix's ability to combat nematodes that have acquired resistance to other classes of wormers.
"This new pack size is aimed at farmers who are introducing new stock to their flocks, but will also be convenient for the smaller sheep farmer and smallholders who don't require such a large quantity of product."
Novartis says that because Zolvix is a short-acting anthelmintic, it does not encourage resistance to develop through a long duration of action. It has a high margin of safety so can be used to treat sheep and lambs including pregnant or lactating ewes and breeding rams. Its short meat withhold period of just seven days allows flexibility when marketing lambs.
The Easy to Give Awards are designed to recognise the commitment made by pharmaceutical companies in making it easier to give prescription-only medications to cats; recognising that medicines which are easier to give make life less stressful for vets, owners and cats alike and ensure better compliance.
Each Easy to Give Award is decided by a feline expert veterinary panel taking into account feedback from their clients. And the winners are ...
These companies will be granted the use of the Easy to Give logo on advertising to the veterinary world. These bring the total number of Easy to Give awards presented, since their inception in 2005, to 39.
International Cat Care also announced the winners of the Cat Friendly Awards, which recognise other products that have made a real difference to cat wellbeing and welfare.
For more details on the work of the charity go to www.icatcare.org.
Liz set up vetsnet to bring together all the wellbeing, leadership and management tools being created by individuals, groups and veterinary organisations in one place, and then to curate, streamline and signpost resources to increase accessibility and use by everyone in the profession.
The Aviva scheme is open to anyone and offers the chance to get funding for an important cause within a community. If successful in its bid, Liz says it will allow Vetsnet to rebrand more clearly as a resource hub, increase ease of use and add user ratings, which in turn will help users to find the help they need when they need it.
Liz said: "I setup Vetsnet to meet needs experienced personally in practice life. Great work is being done to address the mental health and organizational issues within the profession, I wanted to curate, signpost and increase accessibility to the growing wealth of resources for all involved in the provision of veterinary services, to make it a happier profession."
Voting closes on 21st November. To add your support to the bid, go to https://community-fund.aviva.co.uk/voting/project/view/17-1093, register, opt out of mailing options and cast up to 10 votes for a single or multiple projects. Those with the most votes will be judged and finalists announced in the new year.